Profil
Elliot Maltz is currently the Chief Financial Officer & Treasurer at Alimera Sciences, Inc. Prior to his current position, he held various roles including Manager-Technical Accounting at Sapient Corp from 2013 to 2014, Chief Financial Officer & Treasurer at Gelesis, Inc. from 2015 to 2022, Chief Financial Officer, Secretary & Treasurer at Orgenesis, Inc. in 2023, Auditor at Deloitte & Touche LLP from 2007 to 2013, and Treasurer, Chief Financial & Accounting Officer at Gelesis Holdings, Inc. in 2022.
Mr. Maltz completed his undergraduate degree at Elon University.
Postes actifs de Elliot Maltz
| Sociétés | Poste | Début |
|---|---|---|
| ALIMERA SCIENCES, INC. | Directeur Financier/CFO | 02/01/2024 |
Anciens postes connus de Elliot Maltz
| Sociétés | Poste | Fin |
|---|---|---|
| ORGENESIS INC. | Directeur Financier/CFO | 31/12/2023 |
| GELESIS HOLDINGS, INC. | Directeur Financier/CFO | 15/08/2023 |
| GELESIS INC | Directeur Financier/CFO | 01/01/2022 |
| SAPIENT CORPORATION | Comptroller/Controller/Auditor | 01/03/2014 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Comptroller/Controller/Auditor | 01/04/2013 |
Formation de Elliot Maltz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Sapient Corp.
Sapient Corp. Miscellaneous Commercial ServicesCommercial Services Provides consultancy and interactive marketing services | Commercial Services |
Alimera Sciences, Inc.
Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Gelesis, Inc.
Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases | Health Technology |
Orgenesis, Inc.
Orgenesis, Inc. Packaged SoftwareTechnology Services Offers POCare services platform for biotech companies and hospitals to supply their products and develops potential of cell and gene therapies | Technology Services |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Elon University
Elon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gelesis Holdings, Inc.
Gelesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops superabsorbent hydrogel therapeutics for chronic gastrointestinal, weight management and diabetes | Health Technology |
















